A
$ Value
$1.6M
Shares
82,500
Price
$19
Filed
Jun 11
Insider
Name
Deschatelets Pascal
Title
Chief Scientific Officer
CIK
0001657720
Roles
Officer
Transaction Details
Transaction Date
2025-06-09
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
82,500
Footnotes
This represents stock option award granted on June 9, 2025, which will vest over a two-year period. Specifically, 50% of the options will vest on each of the one-year and two-year anniversaries of the grant date, contingent upon continued service.
Filing Info
Deschatelets Pascal's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-28 | APLS | A | $0 |
| 2026-01-22 | APLS | ▼ | $129K |
| 2026-01-20 | APLS | ▼ | $18K |
| 2026-01-13 | APLS | ▼ | $51K |
| 2025-06-09 | APLS | A | $1.6M |
| 2025-05-21 | APLS | M | $48K |
| 2025-05-21 | APLS | M | $0 |
Other Insiders at APLS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Dolsten Mikael | — | — | 2026-02-27 |
|
Watson David O.
General Counsel
|
— | — | 2026-01-28 |
|
Deschatelets Pascal
Chief Scientific Officer
|
— | — | 2026-01-28 |
|
Francois Cedric
Chief Executive Officer
|
— | — | 2026-03-11 |
|
Sullivan Timothy Eugene
Chief Financial Officer
|
— | — | 2026-04-17 |
| O'Brien Stephanie Monaghan | — | — | 2026-04-06 |
|
Nicholson Nur
Chief Technical Officer
|
— | — | 2026-01-28 |
|
Chopas James George
VP/Chief Accounting Officer
|
— | — | 2026-01-28 |
|
DeLong Mark Jeffrey
Chief Business & Strat Officer
|
— | $8K | 2026-02-11 |
|
Boucher Kelley
Chief People Officer
|
— | — | 2026-01-28 |
|
MELTZER LESLIE
Chief Research and Development
|
— | — | 2026-01-28 |